Obsidian Therapeutics Inc. (OBX) Stock Ticker
OBX right now
Market factors today
Unlock the full OBX picture
About Obsidian Therapeutics Inc.
A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors. Its proprietary cytoDRiVE® technology is designed to precisely regulate the timing and level of protein function by using FDA-approved small-molecule drugs.
OBX stock facts
| Ticker symbol | OBX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $13.9M |
| CEO | Madan Jagasia |
| Employees | 87 |
| Headquarters | Cambridge, MA, US |
| IPO date | 2026-08-04 |
| Website | www.obsidiantx.com |
What you can see for OBX on Tickr
Live OBX price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the OBX report.
Rankings
FAQ
What is the ticker symbol for Obsidian Therapeutics Inc.?
The ticker symbol for Obsidian Therapeutics Inc. is OBX, listed on the NASDAQ.
What is OBX?
A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors. Its proprietary cytoDRiVE® technology is designed to precisely regulate the timing and level of protein function by using FDA-approved small-molecule drugs.